|
Resolution: standard / high Figure 2.
Antibody levels for serotype 23F at vaccination, at 4to 6 weeks after vaccination,
and at 1.5-year follow-up in patients with rheumatoid arthritis (RA) and spondyloarthropathy
(SpA) treated with different antiinflammatory drugs. Antibody levels ≥1 mg/L were considered putative protective (short dashed line).
Crnkic Kapetanovic et al. Arthritis Research & Therapy 2013 15:R1 doi:10.1186/ar4127 |